Guj. Themis Bio.

50
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE942C01045
  • NSEID: GUJTHEM
  • BSEID: 506879
INR
413.70
-13.7 (-3.21%)
BSENSE

Sep 21, 03:55 PM

BSE+NSE Vol: 5.17 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 9.96% vs -11.20% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 9.71% vs -12.56% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 710.14% vs 58.81% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -4.29% vs -17.56% in Mar 2025

Compare Profit and Loss Results of Guj. Themis Bio.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
165.00
2,126.00
-1,961.00
-92.24%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
165.00
2,126.00
-1,961.00
-92.24%
Expenditure (Ex Depriciation)
Stock Adjustments
-9.00
11.00
-20.00
-181.82%
Raw Materials Consumed
30.00
677.00
-647.00
-95.57%
Power & Fuel Cost
31.00
43.00
-12.00
-27.91%
Employee Cost
14.00
476.00
-462.00
-97.06%
Operating Expenses
7.00
166.00
-159.00
-95.78%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
193.00
-193.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
5.00
30.00
-25.00
-83.33%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
90.00
1,774.00
-1,684.00
-94.93%
Operating Profit (PBDIT) excl Other Income
75.00
352.00
-277.00
-78.69%
Other Income
2.00
111.00
-109.00
-98.20%
Operating Profit (PBDIT)
77.00
463.00
-386.00
-83.37%
Interest
2.00
4.00
-2.00
-50.00%
Profit before Depriciation and Tax
75.00
458.00
-383.00
-83.62%
Depreciation
12.00
59.00
-47.00
-79.66%
Profit Before Taxation & Exceptional Items
62.00
399.00
-337.00
-84.46%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
62.00
378.00
-316.00
-83.60%
Provision for Tax
15.00
92.00
-77.00
-83.70%
Profit After Tax
46.00
285.00
-239.00
-83.86%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
237.00
1,948.00
-1,711.00
-87.83%
Profit Available for appropriations
284.00
2,233.00
-1,949.00
-87.28%
Appropriations
284.00
2,233.00
-1,949.00
-87.28%
Equity Dividend (%)
67%
500%
-433.00
Earnings Per Share
4.28
17.56
-13.28
-75.63%
Profit And Loss - Net Sales
Net Sales 165.82 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 9.96% vs -11.20% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 75.53 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 9.71% vs -12.56% in Mar 2025

Profit And Loss - Interest
Interest 2.95 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 710.14% vs 58.81% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 46.68 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -4.29% vs -17.56% in Mar 2025